PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22430753-3	2012	Abiraterone acetate was developed to specifically inhibit cytochrome P450 (CYP)17A1, which is an essential enzyme in the biosynthesis of testosterone.	Abiraterone Acetate	0-19	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	58-83	
22430753-5	2012	However, adverse events resulting from elevated mineralocorticoid levels because of CYP17A1 inhibition, fluid retention and oedema, hypokalaemia, hypertension occurred in significantly more in abiraterone acetate plus prednisone than in placebo plus prednisone.	Abiraterone Acetate	193-212	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	84-91